Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-27 | New | $1,089,996 | $1,089,996 | Equity Only | 06b | SEC link |
| 2024-07-16 | New | $2,000,000 | $2,000,000 | Equity and Debt | 06b | SEC link |
| 2022-11-16 | New | $1,050,003 | $1,050,003 | Equity Only | 06b | SEC link |
| 2022-07-07 | New | $800,000 | $800,000 | Debt Only | 06b | SEC link |
| 2022-02-03 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2021-01-08 | New | $330,000 | $330,000 | Debt Only | 06b | SEC link |
| 2020-05-27 | Amended | $2,214,434 | $1,329,856 | Equity Only | 06b | SEC link |
| 2019-08-12 | New | $884,578 | $884,578 | Equity Only | 06b | SEC link |
| 2017-12-28 | New | $1,842,059 | $1,842,059 | Debt Only | 06b | SEC link |
| 2016-05-31 | New | $500,000 | $500,000 | Equity and Debt | 06b | SEC link |
| 2016-01-25 | New | $40,000 | $40,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Paul Denslow | Director, Executive |
| Mark Driscoll | Director |
| Donna Galluzzo | Director |
| Thomas Jarvie | Director, Executive |
| H. Mark Lunenburg | Director |
| Frank J. Marco | Director |
| William Mc Kenzie | Director |
| Alan Mendelson | Director |
| Patrick O'neill | Director |
| Daniel Wagner | Director |
| Matt Watson | Director |
| David Wurzer | Director |